Cypress Capital Group Buys Shares of 2,650 AstraZeneca PLC (NASDAQ:AZN)
Cypress Capital Group acquired a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, Holdings Channel reports. The institutional investor acquired 2,650 shares of the company’s stock, valued at approximately $206,000. A number of other institutional investors have also made changes to their positions in the business. McClarren Financial Advisors Inc. […]
More Stories
Lisata Therapeutics (NASDAQ:LSTA) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Lisata Therapeutics (NASDAQ:LSTA – Free Report) in a research report sent...
Accretive Wealth Partners LLC Sells 499 Shares of Abbott Laboratories (NYSE:ABT)
Accretive Wealth Partners LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.6% in the third quarter,...
STF Management LP Sells 1,042 Shares of Texas Instruments Incorporated (NASDAQ:TXN)
STF Management LP decreased its stake in shares of Texas Instruments Incorporated (NASDAQ:TXN – Free Report) by 7.3% during the...
Accretive Wealth Partners LLC Lowers Stake in Exxon Mobil Co. (NYSE:XOM)
Accretive Wealth Partners LLC cut its stake in Exxon Mobil Co. (NYSE:XOM – Free Report) by 2.1% in the 3rd...
Virtuals Protocol (VIRTUAL) Trading Down 5.1% Over Last 7 Days
Virtuals Protocol (VIRTUAL) traded 7.7% lower against the dollar during the 1 day period ending at 11:00 AM E.T. on...
Arweave Trading Up 7.9% Over Last Week (AR)
Arweave (AR) traded down 0.1% against the US dollar during the 1-day period ending at 11:00 AM ET on November...